» Articles » PMID: 36289077

Neutrophils As Emerging Protagonists and Targets in Chronic Inflammatory Diseases

Overview
Journal Inflamm Res
Date 2022 Oct 26
PMID 36289077
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Neutrophils are the key cells of our innate immune system with a primary role in host defense. They rapidly arrive at the site of infection and display a range of effector functions including phagocytosis, degranulation, and NETosis to eliminate the invading pathogens. However, in recent years, studies focusing on neutrophil biology have revealed the highly adaptable nature and versatile functions of these cells which extend beyond host defense. Neutrophils are now referred to as powerful mediators of chronic inflammation. In several chronic inflammatory diseases, their untoward actions, such as immense infiltration, hyper-activation, dysregulation of effector functions, and extended survival, eventually contribute to disease pathogenesis. Therefore, a better understanding of neutrophils and their effector functions in prevalent chronic diseases will not only shed light on their role in disease pathogenesis but will also reveal them as novel therapeutic targets.

Methods: We performed a computer-based online search using the databases, PubMed.gov and Clinical trials.gov for published research and review articles.

Results And Conclusions: This review provides an assessment of neutrophils and their crucial involvement in various chronic inflammatory disorders ranging from respiratory, neurodegenerative, autoimmune, and cardiovascular diseases. In addition, we also discuss the therapeutic approach for targeting neutrophils in disease settings that will pave the way forward for future research.

Citing Articles

Investigating ferroptosis-related genes NFE2L2 in neutrophils for ankylosing spondylitis: therapeutic potential of cassia twigs.

Chen T, Zhu J, Zhan X, Zhou C, Huang C, Wu S Sci Rep. 2025; 15(1):8233.

PMID: 40064975 PMC: 11893771. DOI: 10.1038/s41598-025-88775-x.


The emerging role of neutrophil extracellular traps in autoimmune and autoinflammatory diseases.

Zeng L, Xiang W, Xiao W, Wu Y, Sun L MedComm (2020). 2025; 6(3):e70101.

PMID: 40060194 PMC: 11885892. DOI: 10.1002/mco2.70101.


The heterogeneity of neutrophils in cancer and its implication for therapeutic targeting.

Eruslanov E, Nefedova Y, Gabrilovich D Nat Immunol. 2025; 26(1):17-28.

PMID: 39747431 DOI: 10.1038/s41590-024-02029-y.


Epigenetic regulatory mechanism of macrophage polarization in diabetic wound healing (Review).

Song J, Wu Y, Chen Y, Sun X, Zhang Z Mol Med Rep. 2024; 31(1).

PMID: 39422035 PMC: 11551531. DOI: 10.3892/mmr.2024.13367.


New Neutrophil Parameters in Diseases with Various Inflammatory Processes.

Rutkowska E, Kwiecien I, Raniszewska A, Sokolowski R, Bednarek J, Jahnz-Rozyk K Biomedicines. 2024; 12(9).

PMID: 39335529 PMC: 11429323. DOI: 10.3390/biomedicines12092016.


References
1.
Wang L, Wang F, Gershwin M . Human autoimmune diseases: a comprehensive update. J Intern Med. 2015; 278(4):369-95. DOI: 10.1111/joim.12395. View

2.
Garg N, Smith T . An update on immunopathogenesis, diagnosis, and treatment of multiple sclerosis. Brain Behav. 2015; 5(9):e00362. PMC: 4589809. DOI: 10.1002/brb3.362. View

3.
Mocsai A, Walzog B, Lowell C . Intracellular signalling during neutrophil recruitment. Cardiovasc Res. 2015; 107(3):373-85. PMC: 4502828. DOI: 10.1093/cvr/cvv159. View

4.
Moss R, Mistry S, Konstan M, Pilewski J, Kerem E, Tal-Singer R . Safety and early treatment effects of the CXCR2 antagonist SB-656933 in patients with cystic fibrosis. J Cyst Fibros. 2012; 12(3):241-8. DOI: 10.1016/j.jcf.2012.08.016. View

5.
Zhou P, Yang X, Wang X, Hu B, Zhang L, Zhang W . A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020; 579(7798):270-273. PMC: 7095418. DOI: 10.1038/s41586-020-2012-7. View